EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 3.0

Effects of Intravenous Subanesthetic-Dose Esketamine on Early Postoperative Pain in Elderly Patients Undergoing Thoracoscopic Lung Surgery: A Randomized Double-Blind Controlled Trial

Haishu Zhao iD, Zhi Liu, Yue Zhang, Mengna Liu, Yao Ning, Dapeng Gao iD, Kangli Hui, Qing Ji, Lidong Zhang

Drug Design, Development and Therapy · 2025-12 · Volume 19 · 11289-11305

DOI: 10.2147/dddt.s565937 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Drug Design, Development and Therapy, 2025-12. Verfasst von Haishu Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Nanjing Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, People's Republic of Chin…. Hauptthemen laut MEDLINE: Analgesics, Ketamine, Lung, Postoperative Pain. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Thoracic surgery is one of the postoperative surgical procedures with the most severe pain. This study aimed to assess whether intraoperative subanesthetic esketamine could reduce the proportion of elderly patients experiencing moderate-to-severe pain following thoracoscopic lung resection. Patients and Methods: A total of 136 elderly patients undergoing thoracoscopic pulmonary surgery were randomly assigned to two groups: the esketamine group (0.25 mg/kg loading, 0.25 mg/kg/h infusion) and the control group (received normal saline). The primary outcome was the proportion of patients experiencing moderate-to-severe pain on the first postoperative day (POD1), defined as a Numerical Rating Scale (NRS) pain score ≥4 during coughing. The secondary outcomes were the postoperative Athens Insomnia Scale (AIS), Hospital Anxiety and Depression Scale (HADS) scores, opioid consumption, hemodynamics, and adverse events.

Results

The primary outcome incidence was lower in the esketamine group (51.5% [35/68]) than in the control group (69.1% [47/68]; relative risk [RR], 0.75; 95% confidence interval [CI], 0.56-0.99; P = 0.035). The proportion of patients with moderate-to-severe pain in the esketamine group decreased by 25.5%. The analysis revealed an absolute risk reduction (ARR) of 17.6% and a number needed to treat (NNT) of 5.7 (rounded to 6). The incidence of postoperative sleep disturbance (PSD) on POD1 (23.5% vs 44.1%; RR, 0.53; 95% CI, 0.32-0.88; P = 0.011) is lower in patients who receive esketamine. Compared to the control group, the esketamine group demonstrated lower HADS scores and reduced opioid consumption, without significant differences in hemodynamic parameters or an increased incidence of neuropsychiatric adverse events.

Conclusion

This study demonstrated that intraoperative subanesthetic esketamine reduced the proportion of moderate-to-severe pain in elderly patients after thoracoscopic surgery, decreased the incidence of sleep disturbances, improved anxiety and depression scores, and lowered opioid consumption, without increasing neuropsychiatric adverse events.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnalgesicsKetamineLungPostoperative PainThoracoscopyAgedAged, 80 and overFemaleHumansMaleMiddle AgedAdministration, IntravenousDose-Response Relationship, DrugDouble-Blind MethodInfusions, Intravenous

Stichwörter der Autor:innen

esketaminemultimodal analgesiapostoperative analgesiasleepthoracoscopic lung surgery

Substanzen

AnalgesicsEsketamineKetamine

Autor:innen und Institutionen

  • Department of Anesthesiology, Nanjing Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, People's Republic of China.
  • Department of Anesthesiology, Nanjing Jinling Hospital, Medical College of Nanjing Medical University, Nanjing, People's Republic of China.

ORCID-Profile: Haishu Zhao, Dapeng Gao

Zitieren

APA

Zhao, H., Liu, Z., Zhang, Y., Liu, M., Ning, Y., Gao, D., Hui, K., Ji, Q., & Zhang, L. (2025). Effects of Intravenous Subanesthetic-Dose Esketamine on Early Postoperative Pain in Elderly Patients Undergoing Thoracoscopic Lung Surgery: A Randomized Double-Blind Controlled Trial. Drug Design, Development and Therapy, Volume 19, 11289-11305. https://doi.org/10.2147/dddt.s565937

Vancouver

Zhao H, Liu Z, Zhang Y, Liu M, Ning Y, Gao D, et al. Effects of Intravenous Subanesthetic-Dose Esketamine on Early Postoperative Pain in Elderly Patients Undergoing Thoracoscopic Lung Surgery: A Randomized Double-Blind Controlled Trial. Drug Design, Development and Therapy. 2025;Volume 19:11289-11305. doi:10.2147/dddt.s565937

BibTeX
@article{Zhao2025,
  author = {Zhao, Haishu and Liu, Zhi and Zhang, Yue and Liu, Mengna and Ning, Yao and Gao, Dapeng and Hui, Kangli and Ji, Qing and Zhang, Lidong},
  title = {Effects of Intravenous Subanesthetic-Dose Esketamine on Early Postoperative Pain in Elderly Patients Undergoing Thoracoscopic Lung Surgery: A Randomized Double-Blind Controlled Trial},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  volume = {Volume 19},
  pages = {11289--11305},
  doi = {10.2147/dddt.s565937}
}
Kostenlos starten →